scholarly journals New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model

Author(s):  
Timothy K Cooper ◽  
Jennifer Sword ◽  
Joshua C Johnson ◽  
Amanda Bonilla ◽  
Randy Hart ◽  
...  
2018 ◽  
Vol 12 (10) ◽  
pp. e0006811 ◽  
Author(s):  
Mehdi R. M. Bidokhti ◽  
Debashis Dutta ◽  
Lepakshe S. V. Madduri ◽  
Shawna M. Woollard ◽  
Robert Norgren ◽  
...  

2021 ◽  
Vol 9 (3) ◽  
pp. 489
Author(s):  
Kendra J. Alfson ◽  
Yenny Goez-Gazi ◽  
Michal Gazi ◽  
Hilary Staples ◽  
Marc Mattix ◽  
...  

Ebola virus (EBOV) is a negative-sense RNA virus that can infect humans and nonhuman primates with severe health consequences. Development of countermeasures requires a thorough understanding of the interaction between host and pathogen, and the course of disease. The goal of this study was to further characterize EBOV disease in a uniformly lethal rhesus macaque model, in order to support development of a well-characterized model following rigorous quality standards. Rhesus macaques were intramuscularly exposed to EBOV and one group was euthanized at predetermined time points to characterize progression of disease. A second group was not scheduled for euthanasia in order to analyze survival, changes in physiology, clinical pathology, terminal pathology, and telemetry kinetics. On day 3, sporadic viremia was observed and pathological evidence was noted in lymph nodes. By day 5, viremia was detected in all EBOV exposed animals and pathological evidence was noted in the liver, spleen, and gastrointestinal tissues. These data support the notion that EBOV infection in rhesus macaques is a rapid systemic disease similar to infection in humans, under a compressed time scale. Biomarkers that correlated with disease progression at the earliest stages of infection were observed thereby identifying potential “trigger-to-treat” for use in therapeutic studies.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Robert W. Cross ◽  
Zachary A. Bornholdt ◽  
Abhishek N. Prasad ◽  
Viktoriya Borisevich ◽  
Krystle N. Agans ◽  
...  

AbstractMonoclonal antibodies (mAbs) and remdesivir, a small-molecule antiviral, are promising monotherapies for many viruses, including members of the genera Marburgvirus and Ebolavirus (family Filoviridae), and more recently, SARS-CoV-2. One of the major challenges of acute viral infections is the treatment of advanced disease. Thus, extending the window of therapeutic intervention is critical. Here, we explore the benefit of combination therapy with a mAb and remdesivir in a non-human primate model of Marburg virus (MARV) disease. While rhesus monkeys are protected against lethal infection when treatment with either a human mAb (MR186-YTE; 100%), or remdesivir (80%), is initiated 5 days post-inoculation (dpi) with MARV, no animals survive when either treatment is initiated alone beginning 6 dpi. However, by combining MR186-YTE with remdesivir beginning 6 dpi, significant protection (80%) is achieved, thereby extending the therapeutic window. These results suggest value in exploring combination therapy in patients presenting with advanced filovirus disease.


2018 ◽  
Vol 4 (1) ◽  
pp. 79-82 ◽  
Author(s):  
Andreas Rausch ◽  
Thomas Schanze

AbstractThe development of new medicines against virus infections like the Marburg virus disease requires an accurate knowledge of the respective pathogens. Conventionally, this process is very time expensive. In cooperation with the Virology of the Philipps-University in Marburg an automatic tracking algorithm for subviral particles in fluorescence image sequences was developed and programmed. To expand the benefit for the pharmaceutical researchers, also the trackevaluations need to be widely automated. In this work, a new parameterizing-method facing the fractal dimensions of spline interpolated subviral particle tracks is presented and tested with simulated and real data. The results reveal a good potential to classify tracks and, thus, types of subviral particles in infected cells.


2014 ◽  
Vol 30 (S1) ◽  
pp. A181-A182
Author(s):  
Wesley A. Grimm ◽  
Luis Barcena ◽  
Danijela Maric ◽  
Gianguido C. Cianci ◽  
Daniel Stieh ◽  
...  

2010 ◽  
Vol 83 (6) ◽  
pp. 1249-1258 ◽  
Author(s):  
Ching-I Chen ◽  
William K. Reisen ◽  
Aaron C. Brault ◽  
Patricia Pesavento ◽  
David C. Clark ◽  
...  
Keyword(s):  

2017 ◽  
Vol 2017 ◽  
pp. 1-10
Author(s):  
Tingfu Du ◽  
Shuaiyao Lu ◽  
Qinfang Jiang ◽  
Yun Li ◽  
Kaili Ma

Type 2 diabetes mellitus (T2DM) is a metabolic disorder that severely affects human health, but the pathogenesis of the disease remains unknown. The high-fat/high-sucrose diets combined with streptozotocin- (STZ-) induced nonhuman primate animal model of diabetes are a valuable research source of T2DM. Here, we present a study of a STZ rhesus macaque model of T2DM that utilizes quantitative iTRAQ-based proteomic method. We compared the protein profiles in the liver of STZ-treated macaques as well as age-matched healthy controls. We identified 171 proteins differentially expressed in the STZ-treated groups, about 70 of which were documented as diabetes-related gene in previous studies. Pathway analyses indicated that the biological functions of differentially expressed proteins were related to glycolysis/gluconeogenesis, fatty acid metabolism, complements, and coagulation cascades. Expression change in tryptophan metabolism pathway was also found in this study which may be associations with diabetes. This study is the first to explore genome-wide protein expression in hepatic tissue of diabetes macaque model using HPLC-Q-TOF/MS technology. In addition to providing potential T2DM biomarkers, this quantitative proteomic study may also shed insights regarding the molecular pathogenesis of T2DM.


1998 ◽  
Vol 4 (5) ◽  
pp. 512-520 ◽  
Author(s):  
Leigh AM Raymond ◽  
Dennis Wallace ◽  
Nancy EJ Berman ◽  
Joanne Marcario ◽  
Larry Foresman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document